Podcasts
We listen, you get the summary.

The Peter Attia Drive
The GLP-1 era: what comes after semaglutide?
A deep conversation on how incretin-based peptides changed obesity research, and why triple agonists like retatrutide are drawing so much attention in current trials.

Huberman Lab
Copper peptides, skin and tissue repair
An overview of GHK-Cu, the copper-binding peptide found naturally in the body, and the lab research on its role in collagen and wound models.

The Peptide Effect
How to read a certificate of analysis
A practical episode on purity testing: what HPLC and mass-spec results mean, and the red flags to look for when comparing suppliers.

FoundMyFitness
BPC-157 and TB-500: what the recovery research actually shows
A careful look at the two most-discussed repair peptides, separating animal tendon and gut models from the much thinner human evidence.

Huberman Lab
MOTS-c: the peptide made by your mitochondria
An episode on mitochondria-derived peptides and why MOTS-c is being studied for exercise capacity and metabolic health.

The Peter Attia Drive
Growth hormone secretagogues: CJC-1295 and ipamorelin
How GHRH analogues and ghrelin-mimetic peptides differ, and what endocrinologists still want to see before drawing conclusions.

The Dr. Hyman Show
Peptides and longevity: hype vs. evidence
A broad conversation on where peptides fit into longevity research, and how to judge new claims as they appear.

Boundless Life
PT-141 and the melanocortin system
An overview of bremelanotide (PT-141), how it acts on melanocortin receptors in the brain, and what its clinical trials measured.

The Peptide Effect
KLOW: what's in the four-peptide blend?
A breakdown of the KLOW blend — GHK-Cu, KPV, BPC-157 and TB-500 — and why blends are harder to study than single peptides.

Modern Wisdom
GLP-1s, muscle and strength: what lifters should know
A discussion of lean-mass loss during incretin-driven weight loss and how researchers are trying to measure and limit it.